title: A transplantable rat Leydig cell tumor--5. Cellular localization of beta-adrenergic and prostaglandin receptors and their effects on testosterone production.
abstract: The cellular localization of beta-adrenergic and prostaglandin (PG) receptors and their effects on adenylate cyclase activity (AC) and testosterone production in vitro were investigated in a transplantable rat Leydig cell tumor (H-540). Separation of the tumor cells in Percoll gradients revealed that the specific binding of [3H]PGE1 and [125I]Cyanopindolol was found in the same fraction as that of [125I]LH. This fraction--judged by light microscopy of smears--consisted of tumor Leydig cells. In addition, [125I]cyanopindolol was found specifically bound in the red blood cell fraction. In the Leydig tumor cells, approx 25% of the beta-adrenergic receptors was identified as beta 1-receptors, whereas approx 75% of the receptors were of the beta 2-subtype. The AC in Percoll purified Leydig tumor cells was stimulated by hCG (6-fold), PGE1 (2-fold), PGE2 (1.5-fold), PGI1 (2-fold) and isoproterenol (2-fold). The AC in the red blood cell fraction was stimulated by isoproterenol whereas the PGs and hCG had little or no effect. hCG, isoproterenol and PGE1 were able to stimulate testosterone production in vitro. At 44 h incubation, PGE1 was the most potent stimulator of testosterone production. In conclusion, tumor Leydig cells possess hCG, PGE1, PGI2 and beta-adrenergic receptors coupled to the AC. PGE1 and beta-adrenergic agonists stimulate testosterone production after prolonged incubation in vitro.
authors.affiliation: Institute of Pathology, Rikshospitalet, University of Oslo, Norway.
authors.forename: A
authors.initials: A
authors.lastname: Erichsen
authors.forename: F O
authors.initials: FO
authors.lastname: Levy
authors.forename: S
authors.initials: S
authors.lastname: Golf
authors.forename: V
authors.initials: V
authors.lastname: Hansson
mesh_terms: D000527:Alprostadil / Q000378:metabolism; D000818:Animals; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D015232:Dinoprostone; D020120:Iodocyanopindolol; D007545:Isoproterenol / Q000494:pharmacology; D007984:Leydig Cell Tumor / Q000032:analysis* / Q000378:metabolism; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D009368:Neoplasm Transplantation; D010869:Pindolol / Q000031:analogs & derivatives / Q000378:metabolism; D011458:Prostaglandins E / Q000378:metabolism; D051381:Rats; D011943:Receptors, Adrenergic, beta / Q000032:analysis*; D011982:Receptors, Prostaglandin / Q000032:analysis*; D013736:Testicular Neoplasms / Q000032:analysis* / Q000378:metabolism; D013739:Testosterone / Q000096:biosynthesis*
chemical_list: D006063:Chorionic Gonadotropin; D011458:Prostaglandins E; D011943:Receptors, Adrenergic, beta; D011982:Receptors, Prostaglandin; D013739:Testosterone; D020120:Iodocyanopindolol; D007986:Luteinizing Hormone; D010869:Pindolol; D000527:Alprostadil; D015232:Dinoprostone; D007545:Isoproterenol